MedTrace Logo

Monitor System for the Safety of Dabigatran Treatment

NCT02414035 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1496

Last updated 2019-09-23

No results posted yet for this study

Summary

The purpose of this study is to determine whether dabigatran is associated with higher risk of bleeding in Asia area especially in China clinical practice and whether it need to set up a monitor system.

Conditions

Sponsors & Collaborators

  • Ministry of Science and Technology of the People´s Republic of China

    collaborator OTHER_GOV

  • Second Affiliated Hospital of Nanchang University

    lead OTHER

Principal Investigators

  • Xiao s Cheng, MD,PhD · The second hospital affillated of Nanchang University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-22
Primary Completion
2018-03-31
Completion
2018-04-18

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02414035 on ClinicalTrials.gov